Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Biotin is important for metabolism, with specific daily intake recommendations, and deficiency can cause health problems.

In 2019, dermatology and venereology improved skin cancer imaging, advanced in treating skin conditions like psoriasis, and explored the skin microbiome's role in diseases.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

A woman experienced vertigo and hearing loss after weight loss surgery, possibly due to eustachian tube issues from fat loss around ear muscles.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Finasteride for hair loss can cause erectile dysfunction due to tissue fibrosis.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Age-related hair loss is linked to the decline and dysfunction of hair follicle stem cells.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Treatments that reduce oxidative stress and fix mitochondrial problems may help heal chronic wounds.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Early balding men may have insulin resistance, but lifestyle changes can help.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Gastric exclusion surgery caused major weight loss and health improvements but led to some anemia and vitamin deficiencies.